Clinical Trial Update: Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravitreal bevacizumab for low vision due to neovascular age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Age Related Macular Degeneration | Phase 3 | Status: COMPLETED